January 2022
New COVID-19 drug passes phase 2 clinical trial

The new treatment, developed by Avalo Therapeutics with Sanford Burnham Prebys researchers, can mitigate lung damage and improve survival in COVID patients.

Unlike other experimental COVID therapies, CERC-002 does not target the virus itself, instead targeting the immune response associated with the virus to stop the disease from progressing before it becomes fatal.

“We have made a lot of progress in controlling the pandemic with vaccines and other new therapies, but it’s not over yet,” says Carl Ware, Ph.D., director of the Infectious and Inflammatory Disease Center at Sanford Burnham Prebys. “Treatments like this may bring physicians an option to protect infected people from severe illness."


The five-year project, led by Andrei Osterman, Ph.D., will utilize an “evolution machine” to shed new light on how bacteria develop antibiotic resistance.

A strange research ecosystem: Discussing Lyme disease with Victoria Blaho

As an infectious disease immunologist studying Lyme disease, Victoria Blaho, Ph.D., is one of a rare breed.

Her disease of choice is an unusual tick-borne bacterial infection that affects some 476,000 people in America each year, a number that is on the rise.

REAL Action on DEI
Sanford Burnham Prebys to host first-ever Rising Stars Symposium

As part of our ongoing effort to educate and train the innovators of tomorrow, we are inviting early-career researchers from underrepresented groups in the sciences to apply for a scholarship to attend the first-ever Rising Stars Symposium.

Selected Rising Stars will receive an all-expenses-paid trip to the Institute to present their research, network and learn more about postdoctoral opportunities.

New CIRM grant to fund research internships for underrepresented high school students

Thanks to a new grant awarded to Sanford Burnham Prebys by the California Institute for Regenerative Medicine (CIRM), 57 California high school students from underrepresented groups will have the chance to complete a paid internship at the Institute this summer.

The $509,000 grant was awarded to Paula Checchi, Ph.D., Alessandra Sacco, Ph.D., and Evan Snyder, M.D., Ph.D.

Ride with Sanford Burnham Prebys
Sanford Burnham Prebys is gearing up for next year’s Padres Pedal the Cause, an annual fundraising race that invites participants to cycle, spin, run or walk to support cancer research in the San Diego area. The event is scheduled for April 9, 2022, at Petco Park. 

Please Donate
Donate now

Please join Sanford Burnham Prebys as a partner in discovery. Our world-class research programs are dedicated to finding cures for human disease to help individuals and their families. Your gift helps our scientists advance medical research to save lives.
Could you benefit from the CARES Act?

The CARES Act offers a once-in-a-lifetime opportunity to make transformative philanthropic gifts, with significant tax benefits to you and your family. Cash gifts to charities such as Sanford Burnham Prebys are deductible at 100% of adjusted gross income.